Qurient

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • 10% KRW/USD exchange rate move impacts net income and equity by ±KRW 77M in FY2025
• • 10% KRW/EUR exchange rate move impacts net income and equity by ±KRW 1.4B in FY2025

Management Discussion & Analysis

• • Revenue KRW 6.98B (-24% YoY), operating loss KRW 29.76B (-8% YoY), net loss KRW 31.26B (-25% YoY)
• • Pharmaceutical distribution segment revenue decreased KRW 2.19B YoY due to market conditions; segment OP loss worsened by KRW 674M from prior year

Business Overview

• • 2025 consolidated revenue KRW 6.98B, down from KRW 9.18B in 2024, driven by drug distribution and R&D service revenue
• • 2025 R&D expenses KRW 21.52B, R&D to sales ratio 327.64%, up from 222.60% in 2024

What are the latest Qurient DART filings in 2026?

Qurient (KRX code 115180) has filed an annual report on March 18, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Qurient file its most recent annual report?

Qurient filed its most recent annual report on March 18, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Qurient's KRX stock code?

Qurient's KRX stock code is 115180. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 115180 to look up all Qurient disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Qurient file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Qurient.

Where can I find Qurient financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Qurient annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.